Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Encompass Health (EHC)

Encompass Health raises 2025 guidance after first-quarter revenue rises 10.6%

Positive Impact 4 of 5 earnings Written later

Encompass Health reported first-quarter 2025 net operating revenue of $1.46 billion, up 10.6% from a year earlier, and diluted earnings per share from continuing operations of $1.48, up from $1.11. The company raised its full-year 2025 adjusted earnings per share guidance to $4.85 to $5.10, from $4.67 to $4.96, and also named Patrick W. Tuer as Executive Vice President and Chief Operating Officer.

Key points

  • Q1 2025 net operating revenue was $1,455.4 million, up 10.6% from $1,316.0 million in Q1 2024.
  • Diluted EPS from continuing operations was $1.48 versus $1.11; adjusted EPS was $1.37 versus $1.12.
  • Full-year 2025 guidance raised: adjusted EPS to $4.85 to $5.10 (from $4.67 to $4.96) and adjusted EBITDA to $1,185 million to $1,220 million (from $1,160 million to $1,200 million).
  • Patrick W. Tuer, age 41, appointed EVP and COO with a $450,000 base salary; the earnings call is at 9:00 a.m. Eastern on April 25, 2025.

The filing

CompanyEncompass Health (EHC)
Form8-K, current report
Filed with the SECApr 24, 2025, 4:40 PM ET
Accession number0000785161-25-000018

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.